NCT06960655
Improving Lipid Optimization Quality and Treatment Options in ASCVD
Enrolling by Invitation
NAAges 18–95InterventionalTreatmentBrigham and Women's HospitalInvestigator-initiated
~300 participants
Updated 2026-05-18 on ClinicalTrials.gov
What's tested:Referral to Pharmacist-Driven Medication Management ProgramBest-Practice Alert
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Achieving Goal LDL-C
Measured over 6 months after notification
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Benjamin Scirica, M.D., MPH · PRINCIPAL_INVESTIGATOR · Brigham and Women's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
\>18 years old and \<=95 years old
Established Atherosclerotic Cardiovascular Disease
Diabetes
Possible Familial Hypercholesterolemia (FH)
High-Risk Primary Prevention
Exclusion
No PCP, cardiologist, endocrinologist, or nephrologist at MGB
ESRD on dialysis
Enrolled in a hospice program
Advanced dementia
What this trial measures
- Achieving Goal LDL-C6 months after notification
% of participants who achieve LDL-c goal (\<100 mg/dL for high-risk primary prevention, \<70 mg/dL for patients with established ASCVD)